FDA approves new uses for two drugs administered together for the treatment of BRAF-positive anaplastic thyroid cancer Read more
Sylentis Announces the Clinical Results of Tivanisiran for the Treatment of Dry Eye Syndrome Read more
Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter Read more
Ferring Signs Global Agreement to Commercialise Novel Gene Therapy for Bladder Cancer Patients Read more
Innomar Strategies Enhances Commercialization Expertise with Acquisition of Therapeutic Products Read more